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Liposomes containing membrane IL-1, Iak, and the antigen conalbumin were evaluated as
"synthetic antigen presenting cells." The role of these three molecules in macrophage-T cell
interaction was studied by testing their ability toinduce the proliferation ofa T-cell clone specific
to conalbumin (the D10 cell line) or immune spleen cells sensitized three times in vivo with
conalbumin. In the latter case, splenic macrophages were eliminated by adherence and a
lysomotropic agent. The antigen conalbumin was presented on the surface of the liposomes as
native undigested protein. When the liposomes presented native conalbumin, la', and membrane
IL-1, significant proliferation occurred, butiftheliposomes lacked membrane IL-1, theprolifera-
tion ofthe T-cell clone and the spleen cells reached only about 60 percent ofthe previous signal.
Nativeconalbumin andclass II antigenalonewererequired forT-cell activation,whilemembrane
IL-I only amplified the response. When the liposomes were made with only Iak and membrane
IL-1, lacking conalbumin, therewas no proliferation ofantigen-specific target cells. These results
indicated that in this synthetic system, membrane IL-I increases the magnitude ofthe response
but is not essential for theproliferative responseofantigen-specific T cells.
INTRODUCTION
Artificial vesicles, such as liposomes, have been widelyused in avarietyoffunctional
membrane systems [1] to increase the immunogenic properties of a soluble antigen
required for the development of effective vaccines [2] or as a tool to explore the
hapten-carrier phenomenon [3]. It has already been demonstrated that liposomes
reconstituted with a variety of cell surface antigens can replace intact viable tumor
cells in the induction ofspecific allogeneic and xenogeneic cytotoxic T lymphocytes in
vitro [4,5]. In addition, appropriately designed liposomes can replace intact viable
tumor cells in the induction of high levels of antibody directed against a syngeneic
tumor antigen [6]. Thus, the association of complex cell-derived antigens with lipo-
somes appears to enhance immune reactivity in a way similar to that described
originally for defined haptens by Kinsky and Nicolotti [7].
The mechanisms by which the microenvironment and architecture ofan antigen can
regulate its ability to stimulate T cells are not yet well understood. The insertion into
model membranes ofantigens aloneor in association withother molecules such asclass
II major histocompatibility complex (MHC) antigens and/or membrane interleukin
(IL-I) and the use ofthese liposomes as functional antigens, immunogens, or artificial
macrophages could enable us to understand better the molecular requirements for the
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induction of the immune response as well as for T-cell activation. Using artificial
vesicles, Walden et al. [8] studied the minimal requirements ofT-cell activation using
an antigen presenting cell (APC)-cytokine-independent stimulus. For this purpose,
they described the production of synthetic lipid vesicles with inserted class II MHC
molecules and a protein antigen coupled covalently to the lipid to re-create their
supramolecular organization. These vesicles were shown to stimulate cloned helper T
cells and T-cell hybridomas in an antigen-specific MHC-restricted manner in the
absence of APC [8]. In light of these observations, we constructed synthetic APC,
using liposomes presenting on their surface native conalbumin, Ta class II MHC
antigen, and membrane IL-1 in an attempt to determine the requirements for T-cell
activation and the role ofmembrane I1-I in macrophage-T-cell interaction.
MATERIALS AND METHODS
Mice
C3H, C57BL/6, and DBA mice were purchased from the Animal Production Area,
NCI-Frederick Cancer Research Facility (Frederick, MD) and were pathogen-free.
The use of the animals, which were housed in The Smith Research Building facility,
was approved by the Institution's Animal Care and Use Committee.
Chemicals andBiologicals
All the media used were endotoxin-free (detection limit <0.125 ng/ml) as deter-
mined by the limulus amebocyte lysate assay (Associates of Cape Cod, Inc., Woods
Hole, MA). Lipopolysaccharide (LPS) (Escherichia coli 026:66), cholesterol, dithio-
threitol (DTT), and conalbumin were purchased from Sigma Chemical Co. (St. Louis,
MO). [3H]Thymidine (TdR) was purchased from New England Nuclear (Boston,
MA). Dipalmitoylphosphatidylcholine (DPPC) anddipalmitoylphosphatidylethanola-
mine (DPPE) were purchased from Avanti Polar Lipids (Birmingham, AL). N-
Hydroxysuccinimidyl 3-(2-pyridyldithio) propionate (SPDP) was purchased from
Pharmacia Fine Chemicals (Piscataway, NJ). Monoclonal antibodies directed against
MHC antigens (I-ak, I-ab, I-ad) were purchased from Litton Bionetics (Charleston,
SC). Minimum Essential Medium (MEM)-Vitamins (100 X) were purchased from
Mediatech (Washington, DC).
Collection ofPeritoneal Mouse Macrophages
Thioglycollate-stimulated peritoneal macrophages were collected by peritoneal lav-
age from mice given 1.5-ml intraperitoneal injections of thioglycollate broth (Balti-
more Biological Laboratories, Cockeysville, MD) five days before harvest [9]. The
peritoneal exudate macrophages were washed three times (250 g for ten minutes) in
medium and plated for 90 minutes on petri dishes in serum-free MEM (2 percent
MEM-vitamins, 2 mM L-glutamine, 100 U/ml penicillin, 100 ,ug/ml streptomycin).
After 90 minutes, the non-adherent cells were removed by extensive washing and the
remaining adherent cells wererefed with MEM plus 10 percent fetal calfserum (FCS)
with or without macrophage activators. These procedures routinely yield homogeneous
preparations (>95 percent) of phagocytic macrophages, as determined by functional
and morphological criteria [9].
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Collection and Activation ofSpleen Cells
Mice were sacrificed by cervical dislocation and the spleen removed and placed in a
petri dish with Hank's buffered saline solution (HBSS) free of Ca2+/Mg2+. The
spleens were minced in the same buffer and the splenocytes collected afterthree washes
(1,500rpmforten minutes). LPS-stimulated spleencells-lymphoblasts (LPS blasts)-
were generated by a 64- to 84-hour culture of spleen cells in the following medium:
RPMI 1640 supplemented with 2 mg/ml glucose, 2 mM L-glutamine, 100 U/ml
penicillin, 100 lg/ml streptomycin, 5 x 10-5 M 2-mercaptoethanol, 5 mM HEPES, 1
mM sodium pyruvate, and 10 percent fetal calfserum with 50,ug/ml LPS.
Purification ofthe Class IIMHCAntigens
LPS blasts have been shown to have normal levels ofclass I MHC antigen, but three
to five times higher levels of class II antigens [10]. These cells were the source of I-A
(C3H for I-ak, C57 BL/6 for I-ab, and DBA for I-ad). The plasma membranes were
isolated as described [11]. Briefly, 5 x 1010 spleen cells were disrupted by a cell-
rupturing pump, and the plasma membranes were purified using a 41 percent sucrose
and a Percoll (Pharmacia) gradient under alkaline conditions [11]. Enzyme markers
such as 5' nucleotidase demonstrated that the plasma membranes were over 97 percent
pure [11]. The membrane proteins were solubilized by a detergent treatment using 9
mM CHAPS (Pierce, Rockford, IL) and dialyzed against Dulbecco's phosphate
buffered saline (PBS). A glycoprotein pool was obtained by chromatography on lentil
lectin-4 B (Pharmacia) as desribed by Watts et al. [12]. The glycoproteins were eluted
with 10 percent a-methyl-D-mannoside in 0.5 percent (weight per volume) sodium
deoxycholate in 0.01 M Tris/0.14 M NaCl/0.02 percent NaN3 pH 8.3 (NaCl/NaN3).
About 32 mg of glycoproteins were obtained from 5 x 1010 cells. Further purification
was performed by affinity chromatography according to the procedure described by
Turkewitz et al. [10] and by Watts et al. [12].
Monoclonal class 1I-specific antibodies used for the affinity columns were coupled to
sepharose 4B by the cyanogen bromide method (>90 percent coupling efficiency). The
glycoprotein pool was applied to the affinity column, which was then washed in 0.5
percent deoxycholate with 15 mM triethanolamine (pH 8). This process was used as a
first step to remove the nonspecific contaminating proteins. The column was then
washed with 20volumesof0.5 percent (weight pervolume) deoxycholate inTris/NaCl/
NaN3 and then with ten volumes of 30 mM octylglucoside in Tris/NaCl/NaN3. The
class II antigen was eluted with 2 M ammonium thiocyanate in octylglucoside/Tris/
NaCl/NaN3. Prior to its reconstitution, Ia was dialyzed against 0.5 percent sodium
deoxycholate in Tris/NaCl/NaN3. Sometimes dilute fractions were further concen-
trated on a 0.5-ml lentil lectin column before their reconstitution in liposomes.
Purification ofMembrane IL-I
Peritoneal mouse macrophages were activated by 10 ,ug/ml ofLPS for 16 hours and
then the cells were disrupted by a cell-rupturing pump [11]. The plasma membranes
were purified using a 41 percent sucrose and Percoll gradient under alkaline conditions
[11]. The plasma membranes (over 97 percent purity) were suspended in 2 ml of9 mM
CHAPS and kept on ice for 30 minutes. The cell extract was dialyzed at 40C for two
days against DPBS and applied to a lentil lectin-sepharose 4B column to remove the
membrane glycoproteins. The eluted solution was then applied on a monoclonal class
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II-specific antibody column to remove the remaining class II molecules. This eluted
solution was then fractionated by gel filtration chromatography using sephadex G50,
and fractions containing IL-I activity were identified, using the murine DI0 assay (see
below).
Construction ofthe Synthetic APC
Cholesterol was recrystallized three times from ethanol. Dipalmitoyl L-phospha-
tidylethanolamine 3-(2-pryidyldithio) propionate (DPPE-DTP) waspreparedasfollows:
DPPE (10 ,umol) was mixed in chloroform: methanol (9:1, 700,ul). SPDP (Pharmacia)
(12 ,umol in 300 ,lp of methanol), and then 20 ,Amol triethylamine were added. After a
two-hour incubation at room temperature with stirring, the organic phase was washed
with 2 ml of phosphate buffer (0.1 M, NaCl, pH 7.4) and then twice with water. The
organic phase was dried under nitrogen and then lyophilized. The product was
redissolved in chloroform: methanol (9:1). DPPC (13.9 ,mol), cholesterol (5.6 ,mol),
and DPPE-DTP (0.7 ,mol) were mixed and the organic solvent was first evaporated
under nitrogen and then lyophilized for two hours. To the lipid film was added 3 ml
L-buffer (0.01 M HEPES and 0.145 M NaCl, pH 7.45). Once lipids were suspended
by vortexing, the liposomes formed.
Native conalbumin antigen was modified by SPDP as described by Barbet et al.
[13]. Prior to SPDP modification, conalbumin (760 ,g/ml) was transferred to phos-
phate buffer (0.1 M, pH 7.5, 0.1 M NaCl) and incubated with SPDP (20 mol of
SPDP/mol ofprotein) for 30 minutes at room temperature to obtain dithiopropionate
(DTP)-conalbumin. The DTP-conalbumin was activated by conversion ofDTPgroups
to free thiol groups as described by Barbet et al. [13]. Briefly the DTP-conalbumin was
incubated with DTT (50 mM final concentration) for 20 minutes at room temperature.
Free thiol-bearing conalbumin, referred to as conalbumin-SH, was immediately
coupled to liposomes: conalbumin-SH was added to liposomes containing DPPE-DTP
and incubated at room temperature for 24 hours, a sufficient period for the reaction to
come to completion [13]. Protein-bearing liposomes could be separated from uncou-
pled protein by centrifugation (one hour, 48,000 g) or by gel filtration on a small
sepharose 4B column (5 x 1.5 cm) [14]. The protein-bearing liposomes were then
lyophilized and resuspended in phosphate buffer containing both the IL-I activity and
class II MHCantigen. Theforeign protein antigens used were then covalently linked to
the lipids and both membrane IL-I and class II MHC molecules inserted into the lipid
bilayers by their hydrophobic properties.
DIO G4.1 TCell Clone Assayfor IL-1
The Dl0 IL-I-dependent T-cell clone was kindly provided by Dr. Charles Janeway
and maintained in culture as previously described [ 1]. IL-I activity was assayed by
adding 1 x 104 D1O cells/well in 200 ,ul medium containing 10 percent FCS, 2.5
percent sodium pyruvate, 5 x 10-5 2-mercaptoethanol, and 2.5,g/ml concanavalin A.
D1O cell proliferation was assessed by measuring [3H]TdR incorporation during the
final 24 hours ofa 72-hour incubation at 370C. Samples were assayed in twofold serial
dilutions, and the activity determined as the reciprocal of the dilution, giving 50
percent maximal incorporation. The amount of IL-I giving 50 percent maximal
incorporation was defined as 1 unit/ml.
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DJ0 Proliferation UsingSynthetic APC
The D10 murine T-cell clone is IL-I-dependent and conalbumin antigen-specific;
the murine T-cell line can proliferate in response not only to conalbumin presented in
the context of syngeneic I-ak (C3H-spleen macrophages) but also to I-ab alloantigen
and to the membrane and soluble forms ofIL-I when co-cultured with concanavalin A
[11]. Synthetic APC macrophages were built using liposomes bearing the different
selected molecules and adjusted to 500 nmoles oflipid per milliliter ofculture medium.
The Dl0 cells were used no earlier than 21 days after exposure to the feeder cells
(mouse C3H spleen cells) and the conalbumin antigen. The D1O cells were centrifuged
at 500 g for ten minutes and plated at 1 x 104 cells/well in 200 ,l final DIO assay
medium containing the synthetic macrophages. Antigen presentation was assayed by
measuring Dl0 proliferation in response to the synthetic APC built as required and by
measuring [3H]TdR incorporation (0.2,uCi) overnight during the last 16 to 24 hours of
a 72-hour incubation as described [15].
Immune Spleen Cell Proliferation
Mice were immunized three times using conalbumin-liposomes (liposomes bearing
conalbumin antigen) and sacrificed by cervical dislocation. The spleens, harvested on
the fourth week after the third immunization, were dissociated in HBSS without
Ca2+/Mg2+. After three washes in this buffer, the splenic macrophages were removed
by a leucin-O-methylester (LeuOMe) treatment (5 mM in RPMI 1640 serum-free
medium) for 40 minutes at 220C as described [16] and by adherence. The spleen cells
were further washed (1,500 rpm for ten minutes), and 2 x 105 cells in 0.1 ml ofRPMI
1640 medium supplemented with 5 mM glutamine, 10 mM HEPES buffer, 5 x 10-5
M 2-mercaptoethanol, 10 percent FCS were evenly distributed in a 96-well plate. In
the first experiment, serial dilutions of synthetic APC were added to determine the
right protein concentrations, and in the later experiments appropriate dilutions of
synthetic APC (100 g1 in triplicate) were added to each well. The plates were
incubated at 370C in a humidified atmosphere supplemented with 5 percent CO2 for
five days. On the last day, 0.2 ,uCi of [3H]TdR was added to the culture (overnight
labeling), and the cells were harvested on an automatic cell harvester.
RESULTS
DJO Cell Proliferation: Requirementsfor Native Antigen
To determine the minimal requirements for T-cell activation, synthetic APCs were
prepared, using DPPC/cholesterol/DPPE liposomes bearing the class II MHC mole-
cules (Ia) and membrane IL-1 hydrophobically bound to the lipids and the native
conalbumin antigen covalently linked to the phospholipids (Fig. 1). These synthetic
APCs were then tested for their ability to induce the proliferation of the conalbumin-
specific DI0 T-cell clone. As shown in Table 1, when synthetic APCs were made with
conalbumin, I-ak, and membrane IL-1, D10 proliferation was maximal and optimal
(100 percent = 125,000cpm). The proliferation signal ofthe DI0 cells decreased to 62
percent when the IL-I was removed. When the lipsomes bore I-ak and membrane IL-I
only, the proliferation was weak (5 percent), but the construction of synthetic APC
with conalbumin antigen, I-ab, and membrane IL-1 produced a DI0 proliferation
signal 56 percent of maximal. In the absence of membrane IL-1, the proliferation
signal dropped down to 39 percent, approximately the same (34 percent) as the signal
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FIG. 1. Schematic representation of the preparation of synthetic macrophages. A.
Modification of the amino groups of protein antigens to produce free thiol groups. B.
Preparation of liposomes with modified PE containing a reactive DTP group. C. Covalent
coupling of the thiol-bearing liposome. D. Lyophilization of the protein-coupled liposomes
and rehydration with an aqueous phasecontaining the hydrophobic membrane IL-I and/or class
II antigens toyield synthetic macrophages.
intheabsenceofconalbumin antigen and IL-1. Thecombination ofI-aband membrane
IL-I gave a signal equivalent to the combination ofconalbumin/I-ab/membrane IL-1,
53 percentversus 56 percent, respectively. This result can beexplained by thefact that
the DI0 T-helper clone may be activated by I-aballoantigen [15]. When I-ad was used
as the MHC class II antigen to construct the synthetic APC, essentially no prolifera-
tion was observed.
DJO Cell Proliferation Kinetics UsingNative Conalbumin
We next investigated the influence ofmembrane IL-I on the magnitude ofthe DI0
responseand on how earlythe DI0proliferation plateau was reached. Forthat purpose,
synthetic APCs bearing I-ak/conalbumin/membrane IL-I were compared with syn-
thetic APCs bearing I-ak/conalbumin for their ability to stimulate the DI0 cells (Fig.
2). When the D1O cells were stimulated by synthetic APC bearing lak/conalbumin/
membrane IL-1, the magnitude of the T-cell clone proliferation was higher (120,000
cpm) and the plateau ofthis response was reached sooner (50 to 55 hours) than when
the DI0 cells were stimulated by lak/conalbumin macrophages. In the absence of
membrane IL-1, the magnitude ofthe DI0 cell response was around 77,000 cpm, and
the plateau was reached at 72 hours.
Immune Spleen Cell Proliferation Requirements UsingNative Conalbumin
C3H mice were immunized three times in vivo by conalbumin-liposomes, and the
immune spleen cells were harvested, separated from splenic macrophages by LeuOMe
100ANTIGEN PRESENTATION BY LIPOSOMES
TABLE 1
Proliferation ofthe DlO T-Cell Clone in Response to Conalbumin Antigen
Dl0 Proliferationc
Class IIb
Liposomes Containinga Types cpm %
Class II + IL-ld + Conalbumin' lak 125,000f 100
Iab 70,000 56
lad 2,500 2
Class II + Conalbumin' Iak 77,500 62
lab 48,700 39
lad 1,250 1
Class II + IL-1' Iak 6,250 5
Iab 66,200 53
lad 1,500 1
Class II Iak 2,000 1
Iab 42,500 34
lad 1,250 1
°Phosphatidylcholine (DPPC: 13.9,umol), cholesterol (5.6 Amol), and DPPE-DTP (0.7Amol) wereused to
prepare the liposomes at a concentration of500 nmol oflipid/ml ofculture medium (50 nmol/well).
bThe class II MHC molecules were purified as described from a whole cell lysate by lentil lectin
chromatography followed by chromatography on respective antibody-sepharose 4B. 18 Ag ofIa/Amol of
lipid was used.
CD10 G4.1 IL-2-dependent murine T-cell clone can proliferate in response to conalbumin presented in the
context of syngeneic I-Ak, but also to I-Ab alloantigen and to IL-I (membrane and soluble forms) when
co-cultured with concanavalin A.
dMembrane IL-I wasextracted asdescribed in Materials and Methods. Membrane IL-I wasequivalent to
100 total units/,mol oflipid representing the activity of45 units of IL-I b (Genzyme)/1,000 Ml ofassay
medium. Membrane IL-I liposomes did not induce D1O proliferation (2,800cpm).
'Conalbumin (250,g/ml) was used as antigen, and approximately 40 percent ofthestarting material was
covalently bound to the liposomes; 35.8 gg ofconalbumin/Mmol oflipid was used. Conalbumin-liposomes
were not able to induce D10 proliferation (3,000 cpm).
fAll values shown were found to havep < 0.005 by the student's t test.
treatment plus adherence, and tested for their ability to proliferate in the presence of
synthetic APC (Table 2). When synthetic APCs were prepared with lak conalbumin/
membrane IL-1, optimal spleen cell proliferation occurred (100 percent = 20,000
cpm). Without membrane IL-1, only 60 percent of the previous signal was observed,
and none when liposomes bore only lak (5 percent). Synthetic APC built with both
140 FIG. 2. T-helper cell clone prolifera-
Class II + MbIL 1 + Ag tion induced by synthetic macrophages.
120 The DIO IL-2-dependent, antigen-spe-
cific murine T-cell line could be acti-
100o vatedinculturebyencountering antigen
(conalbumin) and syngeneic Ia mole-
cpm x cules on the surface ofAPC (C3H mac-
io-3 60 Class II + Ag rophages). Antigen presentation was
assayed by measuring D1O prolifera-
40 - / / tion (2 x 104 cells/well) in response to
synthetic macrophages bearing either
20 - Iak/conalbumin/membrane IL-I (0) or
0 Iak/conalbumin (0). Tritiated thymi-
1 2 3 4 5 6 7 dine incorporation was used to deter-
days mine DI0proliferation.
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TABLE 2
Proliferation ofSpleen Cells Sensitized with Conalbumin Antigen
Spleen Cell Proliferationc
Without Treatment AfterTreatmentd
Class IIb
Liposomes Containinga Types cpm % cpm %
Class II + IL-1' + Agf Ia' 38,0009 100 20,000 100
I-ab 15,600 41 3,000 15
I-ad 14,800 39 3,400 17
Class II + Ag I-a' 32,700 86 12,000 60
I-ab 9,500 25 800 4
I-ad 8,700 23 1,000 5
Class II + IL-1 I-a' 9,100 24 5,600 28
I-ab 3,800 10 3,000 15
I-ad 3,800 10 3,500 17
Class II I-ak 1,900 5 1,000 5
I-ab 1,500 4 600 3
I-ad 1,900 5 600 3
aLiposomes were at a concentration of500 nmoloflipid/ml ofculture medium.
bClass II molecules werepurified asdescribed by lentil lectin chromatography followed by an anti-class II
molecule antibody sepharose 4B. 18 MgofIa/Mmol oflipid was used.
CC3H mice were immunized three times in vivo with conalbumin antigen presented on the liposome
surface.
dSpleen macrophages were removed using adherence and LeuOMe (5 mM) treatments.
'Membrane IL-1 activity was 100units/Mmol of lipid as measured by the D1O assay. Membrane IL-1
liposomes did not induce spleen macrophage-depleted cell proliferation (950 cpm).
fConalbumin was used as antigen to induce spleen cell proliferation. 35.8 Mg ofconalbumin/,umol oflipid
was used. Conalbumin-liposomes did notinduce macrophage-depleted spleen cell proliferation (800cpm).
gAll values shown werefound to havep < 0.005 bythestudent's t test.
membrane IL-I and conalbumin antigen with either Iab or lad produced a very weak
proliferation, 15 percent for lab and 17 percent for Iad. This effect was probably due
solely to membrane IL-1, since synthetic APC presenting both MHC class II antigen
(lab or lad) and membrane IL-I elicited the same spleen cell proliferation signal, and
MHC class II antigen (Iab or lad) synthetic APC did not induce a spleen cell response
(Table 2).
Other experiments (Table 2) were performed in the presence of splenic macro-
phages, since the immune spleen cells were not subjected to a lysomotropic agent and
adherence. Every time the conalbumin antigen was presented on the liposomes, the
proliferation signal was higher in the presence of splenic macrophages than without
splenicaccessorycells (38,000cpmwhen splenicmacrophages were notremoved versus
20,000 cpm when macrophages wereremoved). In allother cases, noobviousdifference
was observed in the degree ofproliferation. Most likely, splenic macrophages phagocy-
tose the liposomes bearing the different molecules, among them the conalbumin
antigen. The splenic macrophages then process the conalbumin antigen and present it
to the splenic T helper cells.
Immune Spleen Cell Proliferation Kinetics Using Native Conalbumin
Spleen cell proliferation in response to synthetic APC bearing lak/conalbumin with
or without membrane IL-I was measured for kinetics and magnitude (Fig. 3). Immune
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FIG. 3. Kinetics of the spleen cell proliferation induced by
synthetic macrophages. C3H mice were immunized three times
in vivo with conalbumin liposomes. The spleens were harvested
on the fourth week after the third immunization and dissociated
in HBSS. The spleen cells were further washed and 2 x IO' cells
in RPMI 1640 medium were distributed in a 96-well plate. To
determine the minimal concentration of proteins required to
induce cell proliferation, serial dilutions of synthetic macro-
phages were used in triplicate. Spleen cell proliferation induced
by lipsomes bearing Iak, native conalbumin, and membrane IL-I
(0) is compared with spleen cell proliferation induced by lipo-
somes bearing lak and native conalbumin (0). Concentration of
Iak was 18 Mg/umol oflipid, theconcentration ofnative conalbu-
min was 35.8 ug/Mmol of lipid, and membrane IL-1 was 10
units/Amol oflipid.
spleen cell proliferation in the presence of membrane IL-I on the synthetic APC was
higher (30,000 cpm with membrane IL-I versus 16,000 cpm without) and the plateau
was more rapidly reached, in three days with membrane IL-I versus five days without.
DISCUSSION
Our understanding ofthe function ofAPC in T-cell activation is steadilyexpanding.
It appears that the first function ofAPC is the processing and subsequent presentation
ofantigens in a form appropriate for recognition by T cells [17-19]. It is clear that Ia
antigens expressed on the surface of Ia-positive APC provide one signal to T cells
necessary for them to recognize either syngeneic or allogeneic Ia alone or Ia in
association with conventional non-MHC antigens [20-22]. In addition, it appears that
a second signal for T-cell activation is provided by APC through mediators such as
IL-1 [23]. Todetermine the minimal andoptimal requirements ofT-cell activation, we
madesynthetic APC byconstructing liposomes carrying oneor moreofa nativeforeign
protein antigen, membrane IL-1, and Ia molecules. We could thus test whether these
different artificial macrophages could activate antigen-specific class II restricted T
cells in the absence ofAPC.
In these studies, we used as proliferative cells the DI0 G4.1 antigen-specific murine
T-cell line or immune spleen cells from mice sensitized three times with conalbumin.
Dl0 is a helper T-cell clone activated by the antigen conalbumin and syngeneic Ia
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molecules on surface APC. Alternatively, DI0 cells may be activated by APC with a
different histocompatibility antigen, C57 BL/6 (H-2b) spleen macrophages.
When synthetic APCs were constructed using liposomes bearing native conalbumin,
membrane IL-1, and lak as class
II MHC molecules, a maximum proliferative response
was obtained for both the DI
0 cells (Table 1) and the immune spleen cells (Table 2).
When the liposomes bore only native conalbumin and Iak, the proliferation intensity
was around 40 percent less for the DI0 cells (Table 1) and spleen cells (Table 2). In
both cases, a greater and more rapid cell response was obtained with synthetic APC
bearing native conalbumin/membrane IL-1/Iak than with liposomes bearing native
conalbumin/lak (Figs. 2 and 3).
When lad was used as class II MHC molecules, no proliferation was detected, even
when lad was associated with membrane IL-I and native conalbumin (Tables 1 and 2).
In contrast, lab elicited D10 proliferation (around 35 to 40 percent), even when it was
the only molecule at the liposome surface (Table 1). It did not, however, affect spleen
cell proliferation, even when it was presented along with membrane IL-I and conalbu-
min (Table 2). These lab results are not surprising, since the T-cell clone can
proliferate in response to lab alloantigen [15]; however, DI0 proliferation when
membrane IL-I was present (53-56 percent), was greater than when it was not (34-39
percent), (Table 1).
From the data of Tables
1 and 2, we can conclude that the recognition of foreign
antigen together with class II MHC molecules seems to be the only signal required for
the activation of antigen-primed regulatory T cells. Furthermore, "processing" of
antigen by APC is not essential for its recognition by T cells. In agreement with
Walden et al. [8], the fact that intact protein molecules, when coupled to lipid, can
activate T cells indicates that extensive processing is not required to render some
proteins immunogenic for T cells. Thus, although antigen degradation certainly takes
place in macrophages and also in other cell types [24,25], the belief that regulatory T
cells are capable of recognizing only processed antigen [26,27] is not universally valid.
Clearly, though, the existence of T-cell clones with a preference for partially digested
antigens has been demonstrated. [28,29]
When synthetic APC included onlyIak and native conalbumin, the proliferative
response was 40 percent less than that obtained with lak/conalbumin/membrane IL-I
macrophages, showing that membrane IL-1 was complementary but not essential for
T-cell activation (Tables
1 and 2). The comparison of these results raises questions
about the role of membrane IL-1 in macrophage-T-cell interaction. Kurt-Jones et al.
[15] have shown that presentation of foreign protein and alloantigen by fixed macro-
phages was quantitatively related to the expression of membrane IL-1; i.e., antigen
presentation increased with increasing amounts of membrane IL-1. In a different
system such as an allogeneic stimulation of cytotoxic T cells using planar membranes,
Brian and McConnell [30] demonstrated that H-2Kk reconstituted into vesicles is
dependent on added growth factors to stimulate T cells. H-2Kk is recognized by
pre-CTL because a significant response occurred only when vesicles contained antigen;
however, the requirement for exogenous factors indicates that H-2Kk in planar
membranes does not stimulate T cells. By contrast, other studies using H-2Kk
reconstituted into vesicles have shown that cytotoxic T-cell allogeneic stimulation was
not dependent on added growth factors [31-33]. Krieger et al. [34] demonstrated that
the basis for the difference in accessory cell function between resting and activated B
cells is not dependent upon co-stimulator production, because the triggering of the
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T-cell hybrids used has been shown to be independent ofan IL-I requirement [28,35].
They suggested that the difference in accessory cell functional capacity between
resting and activated B cells lies in a difference in their capacity to participate in
antigen-independent cellular interactions with T cells, which may be critical for
subsequent antigen-specific activation of the T cell. The studies of Lipsky and
Rosenthal [36] and Braendstrup et al. [37] havedemonstrated that accessory cells and
T cells initially interact nonspecifically and that this interaction is subsequently
stabilized by antigen-specific interaction. Thus, in the experiments done with native
conalbumin, increased concentrations of antigen were required to achieve T-cell
activation, because the synthetic APC-T-cell interaction occurs less readily with large
proteins.
It appears that the APC-T-cell interaction is a two-step procedure involving
recognition, in which membrane IL-I is not required (even if T-cell stimulation
begins), and T-cell activation, in which membrane IL-1, among other factors, is
needed. This proposal is in agreement with that by Davis and Lipsky [38], in which
T-cell activation requires accessorycells to play at least twodistinct roles: theinitiation
ofthe response requires a signal conveyed by an intact macrophage, one that cannot be
provided byeither a macrophage supernatant such as IL-1 [39,40], TNF [41], or PMA
[38]. The response is then amplified by additional macrophage or macrophage
supernatant factors, in which case PMA can substitute for themacrophage as long as it
is supported by a small number of intact accessory cells [38]. More recently, another
monocyte/macrophage-derived cytokine, TNF-a, was found to enhance T4 cell prolif-
eration induced by antigen-bearing paraformaldehyde-fixed monocytes [41]. The
authors concluded that TNF-a facilitated mature T-cell proliferation and therefore
was similar in its action to IL-1 [41].
In Table 2, we have shown that another application of the synthetic macrophage is
the presentation of antigen to splenic macrophages, thus acting like an artificial
immunogen. The liposomes bearing membrane IL-1, lak, and native conalbumin were
probably phagocytosed by the accessory cells, where the antigen was processed and
presented to the immune Tcells. This tool can beused to increase our understandingof
the role of the supermolecular organization of antigen in the expression of its
immunogenicity and could help to elucidate how the antigen microenvironment affects
the immune recognition process. In addition, it may provide valuable information for
designing and preparing appropriate vehicles for syntheticvaccines.
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